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Oxidative stressPresenilin-associated protein (PSAP) has been identiﬁed as a mitochondrial proapoptotic protein. However,
the mechanism by which PSAP induces apoptosis remains unknown. To this end, we have established an in-
ducible expression system. Using this system, we have examined the roles of B-cell lymphoma 2 (Bcl-2) fam-
ily proteins, cytochrome c, Smac (Smac/Diablo, second mitochondria-derived activator of caspases/direct IAP
binding protein with low PI), and Apaf-1 (apoptotic protease-activating factor) in PSAP-induced apoptosis.
Our results demonstrate that knockdown of Apaf-1 abolished PSAP-induced caspase activation and poly(ADP
ribose) polymerase (PARP) cleavage, indicating that the apoptosome formation triggered by cytochrome c
is crucial for PSAP-induced apoptosis. Our data also demonstrate that knockdown of Smac abolished
PSAP-induced caspase activation and PARP cleavage, indicating that, in addition to Apaf-1 or apoptosome for-
mation, Smac is also essential for PSAP-induced apoptosis. However, interestingly, our data demonstrate that
overexpression of Bcl-2 and Bcl-xL did not protect cells from PSAP-induced apoptosis, and that knockdown
of Bid, Bax, and Bak had no effect on PSAP-induced cytochrome c and Smac release, indicating that
PSAP-induced apoptosis is not regulated by Bcl-2 family proteins. These results strongly suggest that PSAP
evokes mitochondrial apoptotic cascades via a novel mechanism that is not regulated by Bcl-2 family pro-
teins, but that both the formation of cytochrome c-Apaf-1 apoptosome and the presence of Smac are abso-
lutely required for PSAP-induced apoptosis.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Apoptosis is a highly regulated and programmed form of cell
death [1]. It not only plays critical roles in the regulation of normal
development and homeostasis of multicellular organisms but is also
critical in removing unwanted and potentially hazardous cells,
such as tumor cells, virus-infected cells, and damaged cells; for re-
view see [2]. Dysregulation of apoptosis has been implicated in the
pathogenesis of several human diseases, such as cancer, autoimmuni-
ty, AIDS, and neurological disorders including Alzheimer's disease
[3–6].P, poly(ADP-ribose) polymerase;
mk, benzyloxycarbonyl-Val-Ala-
in; DISC, death-inducing signal-
ctor 1; Smac/DIABLO, second
gproteinwith lowPI; IAP, inhib-
, siRNA, Small interfering RNA,
nd Diagnostic Sciences, College
ver Drive, Knoxville, TN 37996,
rights reserved.Apoptosis is primarily executed by a family of proteases known as
caspases, which work by disassembling a cell [7,8]. Caspases are acti-
vated by proteolytic processing and are broadly divided into initiator
caspases (e.g. procaspase-8 and -9) and executioner caspases (such as
procaspase-3 and -7) [7]. Two major pathways have been identiﬁed
to lead to caspase activation: the extrinsic death receptor pathway
and the intrinsic mitochondrial pathway [9]. In the extrinsic pathway,
upon binding extracellular stimuli, the death receptor recruits adap-
tor protein FADD (Fas-associated death domain) and procaspase-8
to form the death-inducing signaling complex (DISC), leading to the ac-
tivation of the initiator caspase, caspase-8. On the other hand, in the in-
trinsic pathway, dysfunction of mitochondria, caused by a variety of
stress stimuli including UV radiation, DNA damage, growth factor dep-
rivation, and viral virulence factors [10], results in the release of several
proapoptotic proteins including cytochrome c and Smac (second
mitochondria-derived activator of caspases, also known as DIABLO
[direct inhibitor of apoptosis (IAP)-binding protein with low PI]). The
released cytochrome c initiates the formation of the apoptosome
through interaction with Apaf-1 (apoptotic protease-activating factor)
and recruiting of procaspase-9 in the presence of dATP, leading to the
activation of the other initial caspase, caspase-9 [11]. On the other
hand, the Smac released from mitochondria activates caspase-9 via
binding to IAP [12]. The activated initiator caspases, caspase-8 and
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to apoptosis. The release of these apoptotic factors, such as cytochrome
c and Smac, is generally thought to be controlled by members of B-cell
lymphoma 2 (Bcl-2) family proteins [13].
Presenilin-associated protein (PSAP) was originally identiﬁed as a
protein interacting with presenilin, which is implicated in Alzheimer's
disease pathogenesis. Subsequent study revealed PSAP as a novel mito-
chondrial apoptotic protein that induces apoptosis when it is
overexpressed [14]. However, the details of the molecular mechanism
by which PSAP induces apoptosis remain elusive. To elucidate these
details, using caspase inhibitors and the small interfering RNA (siRNA)
approach, we investigated the roles of the initiator caspase-8 and
caspase-9, the mitochondrial apoptotic factors cytochrome c and
Smac, the Bcl-2 family proteins, and Apaf-1 in PSAP-induced apoptosis.
Our results clearly demonstrate that knockdown of either Apaf-1 or
Smac had no effect on PSAP-induced cytochrome c release but
completely blocked PSAP-induced apoptosis, suggesting that both
apoptosome formation and elimination of IAP inhibition are crucial for
PSAP-induced apoptosis. Inhibition of caspases blocked PSAP-induced,
poly(ADP ribose) polymerase (PARP) cleavage, a sign of execution of
apoptosis, but had no effect on PSAP-induced release of cytochrome c
and Smac, indicating that the release of the proapoptotic factors from
mitochondria is an earlier event in PSAP-induced apoptotic cascades.
However, our result interestingly revealed that PSAP-induced apoptosis
is not protected by overexpression of Bcl-2 and Bcl-xL and that the
proapoptotic Bcl-2 proteins Bax, Bak, and Bid are not required for
PSAP-induced apoptosis, suggesting PSAP induces a unique mitochon-
drial apoptotic pathway that is not controlled by the Bcl-2 family of
proteins.2. Materials and methods
2.1. Reagents
Lipofectamine 2000 transfection reagent, the ponasterone A-inducible
gene expression system, and antibiotics G418 and zeocinwere purchased
from Invitrogen (Carlsbad, CA, USA). Speciﬁc siRNAs and HiPerfect trans-
fection reagent were purchased from QIAGEN (Valencia, CA, USA).
Ponasterone A was from A.G. Scientiﬁc (San Diego, CA, USA). Complete
Protease Inhibitor Cocktail Tablets were purchased from Roche Applied
Science (Indianapolis, IN, USA). Etoposide and the general caspase inhib-
itor benzyloxycarbonyl-Val-Ala-Asp-ﬂuoromethylketone (Z-VAD-fmk)
were purchased from Enzo Life Sciences (Farmingdale, NY, USA). Strepto-
lysin O and β-actin antibody were purchased from Sigma (St. Louis, MO,
USA). Antibodies against PARP, caspase-3/7/8/9, Bcl-2, Bcl-xL, Bax, Bid,
Bak, and Smac were purchased from Cell Signaling Technology (Danvers,
MA, USA); antibodies against Apaf-1 and cytochrome c were purchased
from BD Pharmingen. COX-1 antibody was purchased from Santa Cruz
Biotechnology (Santa Cruz, CA, USA); both anti-mouse IgG and
anti-rabbit IgG secondary antibodies were purchased fromGE Healthcare
(Piscataway, NJ, USA).Fig. 1. Time course of PSAP-induced apoptosis. a. After induction of PSAP expression by
addition of ponasterone A, cells were harvested at various time points, as indicated,
and divided into two portions. Half the harvested cells was directly lysed and separated
by SDS-PAGE, followed byWestern blot analysis. The other half of the cells was used for
preparation of cytosolic extracts and a mitochondria-containing membrane fraction as
described in Materials and methods. Top panel, induction of PSAP expression. Second
panel, PARP cleavage. Third, fourth, ﬁfth, and sixth panels, activation of caspase-3,
caspase-7, caspase-8, and caspase-9, respectively. Activation of caspases was deter-
mined by the formation of active forms of these caspases. One of these membranes
was also re-probed with anti-actin antibody to indicate relative loading of samples
(bottom panel). Seventh panel, cytochrome c release from mitochondria to cytosol.
Eighth panel, Bax translocation from cytosol to mitochondria (mitochondria-containing
membrane fraction). b. The proﬁle of DNA content was determined by ﬂow cytometric
analysis. Left column, results from control cells; right column, results from the
PSAP-expressing cells. Time is indicated in each panel.2.2. Cell culture and transfection
Human embryonic kidney 293 (HEK293) cells were cultured in
DMEM supplemented with 10% fetal bovine serum, 2 mM L-glutamine
(Lonza, Walkersville, MA, USA), 100 units/mL penicillin (Lonza), and
100 μg/mL streptomycin (Lonza). For transfection of 293 cells with
plasmids, the transfection reagent Lipofectamine 2000 (Invitrogen)
was used according to the manufacturer's instructions. For trans-
fection of cells with siRNA, the HiperFect Transfection Reagent
(QIAGEN) was used following the manufacturer's instructions.
Stable cell lines were selected by addition of appropriate antibiotics
as indicated in the text.2.3. Establishment of ponasterone A-inducible expression system in
HEK293 cells
The PSAP expression plasmid was constructed as described previ-
ously [14]. To establish an inducible expression system, PSAP cDNA
was subcloned into the inducible pIND vector. HEK293 cells were
ﬁrst transfected with the regulator vector pVgRXR, which constitu-
tively expresses both subunits of a functional ecdysone receptor
from Drosophila, and a stable cell line was selected with Zeocin
(400 μg/ml). The pVgRXR-stably transfected cells were then further
transfected with the inducible vector pIND bearing the PSAP cDNA,
and the double stably transfected cells were selected with both
Zeocin (400 μg/mL) and G418 (400 μg/mL). Upon addition of the
Fig. 1 (continued).
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stream of the ecdysone responsive promoter in the pIND vector and
activates expression of PSAP gene.
2.4. Establishment of a stable cell line with a functional Apaf-1-shRNA
expression vector
The Apaf-1 shRNA expression vector from Sigma-Aldrich was
transfected into HEK293 cells using Lipofectamine 2000, and the sta-
ble line was selected by addition of puromycin (5 μg/mL) following
the manufacturer's instructions.
2.5. Subcellular fraction
For examination of cytochrome c and Smac release and Bax reloca-
tion, cytosolic extracts and mitochondria-containing fractions were
prepared by permeabilizing cells with streptolysin O (Sigma-Aldrich)using the method described previously by Mosser et al. [15], with
slight modiﬁcation. Brieﬂy, cells (106) were washed with PBS, collect-
ed by centrifugation, and resuspended in 10 μL of streptolysin O buff-
er (20 mM HEPES, pH 7.5, 250 mM sucrose, 10 mM KCl, 1.5 mM
MgCl2, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol, 0.1 mM
phenylmethylsulfonyl ﬂuoride, and 1× protease inhibitor mixture)
containing 60 units of streptolysin O. After incubation at 37 °C for
25 min, the permeabilization of cells was monitored by trypan blue
staining. At the time when 95% cells were stained, permeabilized
cells were pelleted by centrifugation at 16,000 ×g for 15 min at
4 °C. The supernatant containing the cytoplasmic fraction was then
isolated from the pellet that contained the mitochondrial fraction.
The purity of the cytoplasmic fraction was assessed by conﬁrming
the absence of cytochrome c oxidase 1 (COX-1) with Western analy-
sis. The pellet was lysed in lysis buffer (50 mM Tris, pH 6.85, 8 M
urea, 5% β-mercaptoethanol, 2% SDS, and protease inhibitors) by son-
ication for 30 s. Both the cytosolic and mitochondrial fractions were
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followed by Western blot analysis using antibodies against cyto-
chrome c, Smac, COX-1, and Bax.
2.6. siRNA treatment
Small interfering RNA against Apaf-1, caspase-9, caspase-8, Smac,
Bax, Bak, and Bid and the control non-silencing siRNA duplex that
does not target any sequence in the genome were purchased from
QIAGEN. Cells were transfected with these siRNAs three times at
2-day intervals using HiPerfect transfection reagent (QIAGEN), fol-
lowing the instructions provided by the manufacturer. On day 5,
cells were either induced for PSAP expression by the addition of
ponasterone A or transfected with a PSAP-expression plasmid as
indicted in the text. Twenty-four hours after induction of PSAP
expression or transfection with PSAP cDNA, cells were harvested. Half
of the cells was lysed and directly subjected to SDS-PAGE followed by
Western blot analysis; the other half of the cells was used to prepare cy-
tosolic and mitochondrial fractions.
2.7. SDS-PAGE and Western blotting
For analysis of PARP cleavage, caspase activation, and the expres-
sion and subcellular localization of Apaf-1, PSAP, Bax, Bid, Bak, Smac
and cytochrome c, cells and the mitochondria-containing membrane
fraction were lysed by sonication for 20 s on ice in Western blot lysis
buffer (50 mM Tris–HCl, pH 6.8, 8 M urea, 5% mercaptoethanol, 2%
SDS, and protease inhibitor mixture). After addition of 4× SDS sample
buffer and boiling at 100 °C for 7 min, samples were subjected to
SDS-polyacrylamide gel electrophoresis (SDS-PAGE, 6% for Apaf-1, 9%
for PARP and PSAP, 13% for Bcl-2 and Bcl-xL, 10–15% for caspases,
COX-1, cytochrome c, Bax, Bid, Bak and Smac) and transferred to a
polyvinylidene ﬂuoride membrane (Immobilon-P, Millipore, Billerica,
USA). The membranes were probed with appropriate antibodies as de-
scribed inﬁgure legends. For the cytosolic fraction, sampleswere direct-
ly treated with 4× SDS sample buffer and subjected to SDS-PAGE
followed by Western blot analysis as described previously [14].
2.8. Data analysis
AllWestern blots shown are representatives of ﬁve independent ex-
periments. For statistical analysis, the density of each band was quanti-
ﬁed using theGel Digitizing SoftwareUN-SCAN-IT (Silk Scientiﬁc, Orem,Fig. 2. General caspase inhibitor Z-VAD inhibited PSAP-induced apoptosis and caspase
activation, but not cytochrome c release and Bax translocation. Cells were cultured in
the presence or absence of 100 μM Z-VAD, the general caspase inhibitor. After induc-
tion of PSAP expression for 16 h, half the cells were directly lysed and subjected to
Western blot analysis, and the other half were used for preparation of cytosolic extracts
and mitochondria-containing membrane fraction. a. Top panel, ponasterone A induced
PSAP expression (lanes 2 and 4). Second panel, upon induction of PSAP expression,
PARP cleavage was detected in cells cultured in the absence of Z-VAD (lane 2), but
not in cells cultured in the presence of Z-VAD (lane 4). Third to sixth panels, PSAP in-
duced caspase activation in the absence of Z-VAD (lane 2), but not in the presence of
Z-VAD (lane 4). Seventh and eighth panels, cytochrome c was released from mitochon-
dria into the cytosol upon induction of PSAP expression regardless of whether cells
were cultured in the presence or absence of Z-VAD (lanes 2 and 4). Ninth and tenth
panels, PSAP-induced Bax translocation from cytosol to mitochondria was blocked by
Z-VAD (compare lanes 4 with lane 2). Eleventh and twelfth panels, Smac was released
frommitochondria to cytosol upon induction of PSAP expression regardless of whether
cells were cultured in the presence or absence of Z-VAD (lanes 2 and 4). Thirteenth and
fourteenth panels, reprobes of the eleventh and twelfth panels with anti-COX I antibody
to conﬁrm the mitochondria remained intact during preparation. The membrane in the
second panel was also re-probed with anti-actin antibody to indicate relative loading of
samples (bottom panel). b. Quantiﬁcation and statistical analysis of the release of cyto-
chrome c and Smac and translocation of Bax under different conditions. Single, double,
and three asterisks indicate signiﬁcant differences between control and treatment at
pb0.05 0.01, and 0.001 respectively.UT, USA). The ratios of protein levels between treated samples and con-
trols are expressed as mean±SEM, n=5. A single comparison analysis
wasmade using two-tailed unpaired Student t tests. For t tests, p values
of ≤0.05 were considered statistically signiﬁcant.
Fig. 2 (continued).
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A ﬂow cytometric assay was performed as described previously
[14].
3. Results
3.1. Time course of PSAP-induced apoptosis
To determine the mechanism by which PSAP induces apoptosis,
we have established an Ecdysone-Inducible Expression System
(with ponasterone A) [16] for inducible expression of PSAP in
HEK293 cells; we performed a time-course experiment to analyze ap-
optosis upon induction of PSAP. At various time points, equal num-
bers of cells were harvested, and the expression of PSAP, cleavage of
PARP, activation of caspases, and the translocation of mitochondria
pro-apoptotic proteins were analyzed by Western blot. As reported
in our previous study, PSAP is expressed in two isoforms as a resultof alternative splicing, and both isoforms are equally apopototic ac-
tive [17]. As shown in the top panel of Fig. 1a, 4 h after addition of
the inducer ponasterone A, the induced expression of PSAP became
detectable. Note that the recombinant PSAP had a slightly slow mi-
gration rate; this is because the recombinant PSAP was expressed
with a myc-tag fused to its C-terminal [17]. At 8 h PSAP induction,
the 85-kDa fragment of PARP, which is characteristic of apoptosis, be-
came detectable and increased in a time-dependent manner (second
panel). Activation of caspase-9 (sixth panel) and caspase-3 (third
panel) and cytochrome c release (seventh panel) were clearly detected
at an earlier time point, 4 h after induction, but the activation of
caspase-8 (ﬁfth panel) and caspase-7 (fourth panel) was detected at
later time points, 10 and 8 h after induction, respectively. Likewise,
Bax translocation to the mitochondria (eighth panel) was detected at
a later time point 8 h after induction. Since PSAP expression, cyto-
chrome c release, caspase activation, and PARP cleavage all reached
their peak value at 16 h after induction, the following experiments
that used this inducible system were carried out at 16-h time points.
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determining DNA fragmentation. At various time points, cells were
stained with propidium iodide followed by ﬂow cytometric assay.
As shown in Fig. 1b, upon induction of PSAP for 12 h, a signiﬁcant
portion of cells displayed reduced DNA content as demonstrated by
the appearance of the hypodiploid DNA, the sub-Go peak (18%) at
the left of the Go/G1 peak. Cells with lighter DNA staining than that
of G1 cells are considered apoptotic [18]. The percentage of cells asso-
ciated with the sub-Go peak was 24% at the 16-h point in
PSAP-overexpression cells and less than 2% in the control cells.3.2. General caspase inhibitor Z-VAD inhibited PSAP-induced apoptosis
and Bax translocation, but not cytochrome c and Smac release
As shown in Fig. 1, PSAP-induced apoptosis involves caspase acti-
vation and cytochrome c release. To determine the roles of the
caspases in PSAP-induced apoptosis and the translocation of mito-
chondrial proapoptotic factors, the effect of the general caspase inhib-
itor Z-VAD, which irreversibly inhibits all caspase activation, on
PSAP-induced apoptosis was examined. As shown in Fig. 2a, upon in-
duction of PSAP expression at 16 h, PARP cleavage and caspase activa-
tion were clearly observed (lane 2, panels 1 to 6). As expected, upon
induction of PSAP, the level of cytochrome c in the cytosol dramatical-
ly increased with a concomitant decrease in the mitochondrial frac-
tion (lane 2, panels 7 and 8). Similarly, induction of PSAP resulted in
a decrease of Bax in the cytosol, and an increase in the mitochondrial
fraction was clearly detected (lane 2, panels 9 and 10). In addition,Fig. 3. Bcl-2 family proteins had no regulatory effects on PSAP-induced apoptosis. Lanes
5 and 6 show the successful knockdown of Bid (A), Bax (C), Bak (E) individually, and
both Bax and Bak together (G). Since the molecular weight of Bak (25 kDa) is slightly
higher than that of Bax (20 kDa), in the double knockdown cells, Bax and Bak were
probed with a mixture of both anti-Bax and anti-Bak antibodies. a. Knockdown of Bid
had no effect on PSAP-induced caspase activation, PARP cleavage, or cytochrome c re-
lease but blocked the translocation of Bax (compare lane 6 with lanes 2 and 4, third to
eleventh panels). b. Quantiﬁcation and statistical analysis of the Western blot results
for the release of cytochrome c and Smac and the translocation of Bax shown in A. Sin-
gle, double, and three asterisks indicate signiﬁcant differences between control and
treatment at pb0.05 0.01, and 0.001 respectively. c. Knockdown of Bax had no effect
on PSAP-induced caspase activation, PARP cleavage, or the translocation of cytochrome
c and Smac (compare lane 6 with lanes 2 and 4, third to eleventh panels). Twelfth and
thirteenth panels, reprobes of the membranes in the tenth and eleventh panels with
anti-COX I antibody to conﬁrm the mitochondria remained intact during preparation.
The membrane in the second panel was also re-probed with anti-actin antibody to in-
dicate relative loading of samples (bottom panel). d. Quantiﬁcation and statistical anal-
ysis of the Western blot results for the release of cytochrome c and Smac shown in c.
Single, double, and three asterisks indicate signiﬁcant differences between control
and treatment at pb0.05 0.01, and 0.001 respectively. e and g. Knockdown of Bak
and double knockdown of Bax and Bak had no effect on PSAP-induced PARP cleavage,
caspase activation, or the release of cytochrome c and Smac (compare lane 6 with lanes
2 and 4, third to eleventh panels). In this set (e and g) of experiments, cells in lanes 2, 4,
and 6 were transfected with PSAP cDNA (second panel); cells in lanes 1, 3, and 5 were
transfected with a plasmid expressing LacZ (bottom panel). F and H are the quantiﬁca-
tion and statistical analysis of the Western blot results for the release of cytochrome c
and Smac in Bak-knockdown (e) and Bak/Bax-double knockdown (g) cells, respective-
ly. Single, double, and three asterisks indicate signiﬁcant differences between control
and treatment at pb0.05 0.01, and 0.001 respectively. i. Overexpression of Bcl-2 and
Bcl-xL proteins had no effect on PSAP-induced apoptosis. PSAP-inducible expression
cells in lanes 1 and 2 were transfected with empty vector; cells in lanes 3 and 4 were
transfected with a plasmid-expressing Bcl-2 (top panel); cells in lanes 5 and 6 were
transfected with a Bcl-xL-expressing plasmid (second panel). The third panel was
probed for inducible expression of PSAP; the fourth panel was probed for cleavage of
PARP; ﬁfth to eighth panels were probed for caspase activation; ninth to thirteenth
panels were probed for cytochrome c, Smac, and COX-1 in the cytosolic and mitochon-
drial fractions; twelfth panel was probed for β-actin. j. Quantiﬁcation and statistical
analysis of the Western blot results for the release of cytochrome c and Smac shown
in i. k. Single, double, and three asterisks indicate signiﬁcant differences between con-
trol and treatment at pb0.05 0.01, and 0.001 respectively. Overexpression of Bcl-2
blocked etoposide-induced apoptosis. l. Knockdown of Bax and Bak blocked
etoposide-induced apoptosis.upon induction of PSAP, mitochondrial release of the other important
mitochondrial proapoptotic factor Smac was also detected (lane 2,
panels 11 and 12). When the cells were treated with the general
caspase inhibitor Z-VAD (100 μM) for 30 min prior to induction of
PSAP, the PSAP-induced apoptosis was blocked as determined by
the blockage of caspase activation (lane 4, panels 3 to 6) and the dis-
appearance of PARP cleavage (lane 4, second panel). It was also noted
that in the presence of the caspase inhibitor, Bax translocation from
cytosol to mitochondria was also blocked (lane 4, panels 9 and 10),
indicating that Bax translocation depended on the activation of
caspase. However, as shown in lane 4 of panels 7, 8, 11, and 12, the
release of cytochrome c and Smac from mitochondria was not affect-
ed by inhibition of caspase activity. This result strongly suggests that
the releases of cytochrome c and Smac from the mitochondria were
independent of caspase activation and are the early events in
Fig. 3 (continued).
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tors cytochrome c, Smac/Diablo, and Bax, the Western blot results of
ﬁve independent experiments were quantiﬁed and normalized to
the level of β-actin. As shown in Fig. 2b, regardless of presence or ab-
sence of Z-VAD, PSAP-induced cytochrome c (top row) and Smac
(bottom row) releases were signiﬁcant. However, in contrast with
absence of Z-VAD, no signiﬁcant translocation of Bax from cytosol to
mitochondria was observed in the presence of Z-VAD (middle row).
3.3. The proapoptotic Bcl-2 family proteins are not required for
PSAP-induced apoptosis
To determine whether the proapoptotic Bcl-2 proteins play a role
in PSAP-induced apoptosis, the effects of knockdown of these pro-
teins on PSAP-induced apoptotic events were explored. To knock-
down these proteins, cells were transfected with siRNAs speciﬁc to
Bax, Bak, and Bid using HiPerfect transfection reagent (QIAGEN),
following the instructions provided by the manufacture as describedin “Materials and methods.” To determine the effect of knockdown
of Bax and Bid, cells that inducibly express PSAP were used. Since
knockdown of Bak attenuates inducible expression of PSAP for an un-
known reason, the effects of knockdown of Bak and Bax/Bak double
knockdown were examined in native HEK293 cells. As shown in
Fig. 3a, after 5 days' treatment with siRNA against Bid, Bid expression
was completely knocked down (lanes 5 and 6, top panel). In contrast,
when the cells were treated with non-silencing control siRNA, the
expression level of Bid and the PSAP-induced apoptotic response
were not affected in comparison with cells treated with only transfec-
tion reagent (compare lane 4 with lane 2 through all the panels). As
shown in the third panel, knockdown of Bid had almost no effect on
PSAP-induced PARP cleavage (compare lane 6 with lanes 2 and 4).
As discussed below, the slight decrease in the level of cleavage of
PARP may reﬂect the effect of the attenuation of the ampliﬁcation
loop mediated by caspase-8 and tBid. As shown in panels 4 to 7,
knockdown of Bid had no signiﬁcant effect on PSAP-induced caspase
activation (compare lane 6 with lanes 2 and 4). As shown in panels
Fig. 3 (continued).
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PSAP-induced release of cytochrome c and Smac/Diabio from mito-
chondria into the cytosol (compare lane 6 with lanes 2 and 4). How-
ever, as shown in panels 10 and 11, knockdown of Bid almost
completely blocked Bax translocation from cytosol to mitochondria
(compare lane 6 with lanes 2 and 4). Results of theWestern blot anal-
ysis for cytochrome c, Smac/Diablo, and Bax were quantiﬁed and
normalized to the level of β-actin. As shown in Fig. 3b, regardless of
Bid knockdown, PSAP-induced cytochrome c (top row) and Smac
(bottom row) releases were signiﬁcant. However, in contrast with
non-silencing siRNA treated cells, no signiﬁcant translocation of Bax
from cytosol to mitochondria was observed in cells treated with
Bid-speciﬁc siRNA (middle row). These results clearly indicate that
PSAP-induced apoptotic events, including caspase activation, PARPcleavage, and cytochrome c release, were Bid independent. However,
Bid was required for PSAP-induced Bax translocation.
The results presented above that knockdown of Bid blocked Bax
translocation but had no effect on apoptosis suggest that Bax is not
required for PSAP-induced apoptosis. To address this issue, we deter-
mined the effect of knockdown of Bax on PSAP-induced apoptosis. As
shown in the top panel of Fig. 3c, after 5 days' treatment with
Bax-speciﬁc siRNA, Bax was completely knocked down (lanes 5 and
6). As shown in the third panel, knockdown of Bax had almost no
effect on PSAP-induced PARP cleavage (compare lane 6 with lanes 2
and 4). As mentioned above, the slight decrease in the level of cleav-
age of PARP may reﬂect the effect of the attenuation of the ampliﬁca-
tion loop mediated by caspase-8, tBid, and Bax. As shown in panels 4
to 7, knockdown of Bax had no effect on PSAP-induced caspase activa-
tion, nor did it have a signiﬁcant effect on PSAP-induced releases of
cytochrome c and Smac (panels 8 to 11, compare lane 6 with lanes
2 and 4). Western blot results for cytochrome c and Smac/Diablo
were quantiﬁed and normalized to the level of β-actin. As shown in
Fig. 3d, regardless of Bax knockdown, PSAP-induced cytochrome c
(top row) and Smac (bottom row) releases were signiﬁcant. These
results clearly indicate that PSAP-induced apoptotic events, including
caspase activation, PARP cleavage, and mitochondrial proapoptotic
factor release, were Bax independent.
Next, we determined the effect of knockdown of Bak, a close relative
of Bax, on PSAP-induced apoptosis. Since treatment with siRNA speciﬁc
to Bak resulted in the impairment of inducible expression of PSAP for an
unknown reason, knockdown of Bak was performed in wild type
HEK293 cells. As shown in Fig. 3e, Bak expression was completely
knocked down after 5 days of treatment with Bak-speciﬁc siRNA
(lanes 5 and 6, top panel). At the time point when knockdown of Bak
was conﬁrmed, the cells were transfected either with PSAP expression
plasmid or with β-galactosidase (LacZ) expression plasmid for 24 h,
and the exogenous expression of PSAP (lanes 2, 4, and 6, second
panel) and LacZ (lanes 1, 3, and 5, bottom panel) were detected by
Western blot using speciﬁc antibodies. As shown in the third panel,
upon transfection with PSAP cDNA, PARP cleavage was clearly detected
in cells treated with transfection reagent only (lane 2), in cells treated
with a non-silencing control siRNA (lane 4), and in cells treated with
Bak-speciﬁc siRNA (lane 6). As shown in panels 4 to 7, PSAP-induced
caspase activation was detected in all PSAP-transfected cells regardless
of whether Bakwas knocked down (compare lane 6with lanes 2 and 4).
As shown in panels 8 to 11, knockdown of Bak had no effect on
PSAP-induced release of cytochrome c and Smac (compare lane 6
with lanes 2 and 4). Quantitative analysis of Western blot results for
cytochrome c and Smac/Diablo revealed that regardless of Bak knock-
down, PSAP-induced cytochrome c (top row) and Smac (bottom row)
releases were signiﬁcant (Fig. 3f). These results indicate that similar to
Bax, Bak was not required for PSAP-induced apoptosis.
The data presented above demonstrate that neither Bax nor Bak
was required for PSAP-induced apoptosis when they were knocked
down individually. We next determined the effect of double knock-
down of Bax and Bak on PSAP-induced apoptosis. As shown in
Fig. 3g, both Bax and Bak were completely knocked down after
5 days' treatment with Bax- and Bak-speciﬁc siRNAs (lanes 5 and 6,
top panel). As shown in the third to seventh panels, upon transfec-
tion with PSAP cDNA, PARP cleavage and caspase activation were
detected in all cell lines regardless of whether Bax/Bak were knocked
down (compare lane 6 with lanes 2 and 4, panels 3 to 7). As shown in
panels 8 to 11, knockdown of Bax and Bak had no effect on
PSAP-induced release of cytochrome c and Smac (compare lane 6
with lanes 2 and 4). Quantitative analysis of Western blot results
for cytochrome c and Smac/Diablo revealed that regardless of Bak
and Bak knockdown, PSAP-induced cytochrome c (top row) and
Smac (bottom row) releases are signiﬁcant (Fig. 3h). These
data clearly indicate that both Bax and Bak were dispensable for
PSAP-induced apoptosis.
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induced apoptosis
The above results clearly indicate that the proapoptotic Bcl-2 pro-
teins are not required for PSAP-induced apoptosis. Next, we determined
whether PSAP-induced apoptosis is regulated by anti-apoptotic Bcl-2
protein. As shown in Fig. 3i and j, overexpression of Bcl-2 and Bcl-xL
had no effect on PSAP-induced apoptosis, as determined by PARP cleav-
age and the release of cytochrome c and Smac/Diablo. Taken together,
these observations strongly suggest that PSAP-induced apoptosis was
not regulated by Bcl-2 family proteins.
As control, we have performed experiments to determine the effects
of Bcl-2 family protein on apoptosis induced by etoposide, which is
a known intrinsic apoptotic inducer and induces Bax- and Bak-
dependent apoptosis regulated by Bcl-2 family proteins [19]. HEK 293
cells transfected with either Bcl-2 cDNA or with siRNAs speciﬁc to Bax
and Bak were treated with 45 μM etoposide (VP-16) for 24 h to induce
apoptosis. As shown in Fig. 3 k and l, etoposide-induced apoptosis was
completely inhibited by either overexpression of Bcl-2 protein or
knockdown of Bax and Bak as reported by previous study [19]. This
result conﬁrms our experimental conditions as accurate.
3.5. Knockdown of caspase-9, but not caspase-8, abolished
PSAP-induced apoptosis
The results presented above indicate that inhibition of caspase
activation with the general caspase inhibitor Z-VAD had no effect on
PSAP-induced release of either cytochrome c or Smac, but blocked
PSAP-induced PARP cleavage. This result clearly indicates that the
execution of PSAP-induced apoptosis depended on caspase activation.
However, this set of data did not answer the question of which
caspase is the initiator caspase in PSAP-induced apoptotic cascades.Next, we determined the role of caspase-9, the initiator caspase of the
mitochondrial pathway, and caspase-8, the initiator caspase in the
death receptor pathway, in PSAP-induced apoptosis. To do so, HEK293
cells expressing inducible PSAP were treated with caspase-9- or
caspase-8-speciﬁc siRNA. As shown in Fig. 4, both caspase-9 and
caspase-8 expression was completely suppressed in cells treated with
speciﬁc siRNAs (lanes 5 and 6, top panel, Fig. 4a and b), but not in
cells treated with either reagent only or non-silencing siRNA (lanes 1
to 4, Fig. 4a and b). As shown in Fig. 4a, upon induction of PSAP expres-
sion, PARP cleavage was detected in control cells (third panel, lanes 2
and 4) but not in cells treated with caspase-9 siRNA (lane 6). As
shown in panels 4 and 5, knockdown of caspase-9 abolished the activa-
tion of caspase-3 and caspase-8 (compare lane 6 with lanes 2 and 4). In
contrast, as shown in Fig. 4b, knockdown of caspase-8 had only a slight
effect on PSAP-induced PARP cleavage and the activation of other
caspases (compare lane 6 with lanes 2 and 4, panels 3 to 6). These
results strongly indicate that caspase-9 was the initiator caspase in
PSAP-induced apoptotic cascade. The slight decrease in the level of
cleavage of PARP and the activation of other caspases in caspase-8
knockdown cells may reﬂect the effect of the abolishment of the ampli-
ﬁcation loop mediated by caspase-8 and tBid as discussed above.
3.6. Knockdown of Apaf-1 abolished PSAP-induced apoptosis, caspase
activation, and Bax translocation, but not cytochrome c release
The results presented above clearly indicate that caspase-9 is cru-
cial in the activation of other caspases and the subsequent cleavage of
PARP. Next, we determined the role of apoptotic protease-activating
factor 1 (Apaf-1), which is a key molecule for the activation of
caspase-9 in the apoptosome, in PSAP-induced apoptosis. HEK293
cells were stably transfected with an Apaf-1-targeting shRNA expres-
sion plasmid as described in Materials and methods. As shown in
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transfected with Apaf-1-targeting shRNA (lanes 3 and 4) but not in
scrambled shRNA-transfected cells (lanes 1 and 2). When these cells
were further transfected with LacZ or PSAP expression plasmid, as
shown in the third panel, PARP cleavage was detected in scrambled
shRNA-expressing cells (lane 2) but not in cells expressing shRNA
against Apaf-1 (lane 4). As shown in panels 4 to 7, knockdown of
Apaf-1 expression attenuated caspase activation induced by PSAP ex-
pression (compare lane 4 with lane 2). These results indicate that
Apaf-1 was required for PSAP-induced apoptosis. As expected, as
shown in panels 8 and 9, knockdown of Apaf-1 had no effect on
PSAP-induced cytochrome c release from mitochondria (compare
lane 4 with lane 2). In contrast, as shown in panels 10 and 11, knock-
down of Apaf-1 completely blocked PSAP-induced Bax translocation
(compare lane 4 with lane 2). Quantitative analysis of Western blotresults for cytochrome c release and Bax translocation are shown in
Fig. 5b.
3.7. Smac is indispensable for PSAP-induced apoptosis
Finally, we examined the role of Smac, which is the other key mito-
chondrial proapoptotic factor promoting caspase-9 activation, in
PSAP-induced apoptosis using an siRNA approach. As shown in Fig. 6a,
treatment of cells that express inducible PSAP with Smac-speciﬁc
siRNA completely suppressed the expression of Smac (lanes 5 and 6).
As shown in panels 3 to 7, knockdown of Smac completely abolished
PSAP-induced apoptotic events including PARP cleavage and caspase
activation (compare lane 6 with lanes 2 and 4). However, similar to
Apaf-1, knockdown of Smac had no signiﬁcant effect on PSAP-induced
cytochrome c release (panels 8 and 9), but blocked Bax translocation
(panels 10 and 11). Quantitative analysis of Western blot results for
cytochrome c release and Bax translocation are shown in Fig. 6B.
These results indicate that both Apaf-1 and Smac were indispensable
for PSAP-induced apoptosis.
4. Discussion
In a previous study, we reported that PSAP is a mitochondrial
proapoptotic protein that causes apoptosis when it is overexpressed
[14]. In the present study, using various approaches, including em-
ployment of inhibitors and siRNA technology, we investigated the
mechanism by which PSAP induces apoptosis. Our results clearly indi-
cate that PSAP induces apoptosis though a unique mitochondrial
pathway that is not controlled by the Bcl-2 family proteins. In con-
trast, both Apaf-1 and Smac are required for PSAP-induced apoptosis.
The apoptotic process is executed by a group of cysteine proteases
known as caspases that speciﬁcally cleave their substrates at aspartic
acid residues [20]. As shown in Fig. 7, caspases are activated through
two major pathways, i.e., the death receptor (extrinsic) pathway and
the mitochondrial (intrinsic) pathway. In the death receptor path-
way, activation of the initiator caspase, caspase-8, is mediated by
the formation of DISC triggered by ligand binding to death receptors,
while in the mitochondrial pathway the initiator caspase, caspase-9,
is activated by the formation of apoptosome initiated by the release
of cytochrome c and its subsequent binding to Apaf-1. The activated
initiator caspases in turn activate the executor/effector caspases,
such as caspase-3, leading to apoptosis via degradation of the nucleus
and other intracellular structures [21]. In some types of cells known
as Type I cells, death receptor-induced activation of the initiator
caspase, caspase-8, can directly lead to the activation of the effector
caspases. On the other hand, in the great majority of cells (Type II
cells), the level of death receptor-induced activation of caspase-8 is
less efﬁcient for direct activation of downstream caspases, but is
enough to promote the cleavage of Bid, a member of the Bcl-2 family
protein. The cleaved Bid (tBid, truncated Bid) then induces cyto-
chrome c release from mitochondria in synergy with Bax and Bak,
the other two proapoptotic members of the Bcl-2 family protein
[21]. Thus, mitochondria play a critical role in both intrinsic and
extrinsic apoptotic pathways. Hence, as a proapoptotic protein, the
mitochondrial localization of PSAP places it in an important position,
and this prompted us to determine the mechanism by which PSAP
induces apoptosis.
By using an inducible expression system, our data demonstrate that
overexpression of PSAP induces a series of apoptotic events including
PARP cleavage, caspase activation, the release of cytochrome c and
Smac frommitochondria, and the translocation of Bax to themitochon-
dria. The data from the time course experiment also demonstrate that
cytochrome c release occurs prior to caspase activation, suggesting
that cytochrome c release is an earlier event in PSAP-induced apoptotic
cascades. This view is further supported by the ﬁnding that inhibition of
caspase activation completely blocked PSAP-induced PARP cleavage,
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Mitochondrial outer membrane permeabilization and the release of
intermembrane space proteins, such as cytochrome c, are generally
thought to require the activation of Bak or Bax, the proapoptotic mem-
bers of Bcl-2 family proteins [13]. In this regard it is notable that inhibi-
tion of caspase activation blocked PSAP-induced Bax translocation, but
had no effect on cytochrome c release. This ﬁnding raised a question
as to whether PSAP-induced cytochrome c release is controlled by
Bcl-2 family proteins. Using the siRNA approach, our data clearly dem-
onstrate that knockdown of Bid, Bax, or Bak individually, and knock-
down of both Bax and Bak simultaneously had no effect on PSAP-
induced cytochrome c release. These results strongly suggest that
PSAP-induced release of cytochrome c is not controlled by these
proapoptotic Bcl-2 proteins. Furthermore, our data clearly demonstrat-
ed that overexpression of Bcl-2 and Bcl-xL did not protect cells from
PSAP-induced apoptosis. Taken together, these observations strongly
suggest that PSAP-induced apoptosis is not regulated by Bcl-2 proteins.
However, these proteins may contribute to PSAP-induced apoptosis via
the caspase-8-tBid ampliﬁcation loop.
As discussed above, there are two initiator caspases, caspase-8 and
caspase-9, mediating the death receptor signaling pathway and mito-
chondrial pathway, respectively. In determiningwhich caspase is the ini-
tiator caspase in PSAP-induced apoptosis, using the siRNA approach, our
data demonstrated that knockdown of caspase-8 had no effect on
PSAP-induced PARP cleavage (Fig. 4), nor caspase-3 and caspase-9 activa-
tion (Fig. 4). These data clearly argue against a role of caspase-8 in med-
itating the initiation of PSAP-induced apoptosis. Conversely, knockdown
of caspase-9 completely abolished PSAP-induced PARP cleavage and the
activation of caspase-3 and caspase-8, suggesting that caspase-9 is the
initiator caspase in PSAP-induced apoptotic cascades. Caspase-9 isbelieved to be activated at the apoptosome, a complex formed by binding
of cytochrome c to Apaf-1 in the presence of dATP in the cytosol [22]. To
determine the role of the apoptosome in PSAP-induced apoptosis, we
examined the effect of knockdown of Apaf-1 on PSAP-induced
caspase-9 activation. The results that knockdown of Apaf-1 completely
abolished activation of caspase-9 and other caspases, aswell as the cleav-
age of PARP, clearly indicate that PSAP-induced caspase-9 activation is
mediated by the Apaf-1-cytochrome c complex.
In addition to cytochrome c, Smac is another important proapoptotic
factor released frommitochondria that promotes cytochrome c-Apaf-1-
dependent caspase activation by neutralizing the inhibitory activity of
XIAP, which is amember of the IAP family of proteins that block caspase
activation [12]. Having shown that Smac was also released from mito-
chondria upon induction of PSAP expression, we wished to determine
whether Smac also plays a role in PSAP-induced apoptosis. We there-
fore examined the effect of knockdown of Smac on PSAP-induced apo-
ptosis. We found that knockdown of Smac completely abolished
PSAP-induced PARP cleavage and caspase activation, indicating that,
in addition to Apaf-1 or apoptosome formation, Smac is also required
for PSAP-induced apoptosis. We also found that cytochrome c release
was not signiﬁcantly affected by knockdown of Smac, indicating that
PSAP-induced cytochrome c release is independent of Smac.
PSAP shares homology within the mitochondrial carrier domain
with mitochondrial carrier proteins [14]. Recently, a protein known
as MTCH2, a close homologue of PSAP, was also reported to be in-
volved in apoptosis [23]. Different from other mitochondrial carrier
proteins, which are localized to the inner mitochondrial membrane
[24], both PSAP and MTCH2 are apparently exposed on the surface
of the mitochondria [17,25]. The biological functions of these two
proteins remain unknown, but both are now implicated in apoptosis.
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tizes cells to apoptotic stimuli by facilitating tBid recruitment through
direct interaction with tBid [23]. In contrast, PSAP induces apoptosis
when it is overexpressed and induces mitochondria dysfunction in a
Bcl-2 protein-independent manner. Thus, PSAP and MTCH2 are in-
volved in apoptosis via apparently different mechanisms. Accumulat-
ing evidence suggests that apoptosis is one of the mechanisms
leading to neuronal cell death in Alzheimer's disease [26,27], and spe-
ciﬁcally, studies strongly suggest the involvement of dysfunction of
mitochondria in neuronal degeneration in Alzheimer's disease
[28,29]. Nevertheless, the molecular mechanism of mitochondrial
dysfunction in Alzheimer's disease remains elusive. In this regard, asshown in Fig. 7, it is notable that PSAP induces release of cytochrome
c and Smac/Diablo in a non-traditional manner, a Bcl-2 protein-
independent manner, suggesting a new mitochondrial dysfunction
pathway. This result may establish a new model for investigation of
mitochondrial apoptosis observed in AD.
In summary, we have shown that PSAP-induced apoptosis re-
quires both the formation of cytochrome c-Apaf-1 apoptosome and
the presence of Smac. More interestingly, PSAP induces the release
of the mitochondrial proapoptotic factors cytochrome c and Smac in
a Bcl-2 protein-independent manner, and this may open a new ave-
nue to study the mechanism of mitochondria-mediated apoptosis.
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Fig. 4. Knockdown of caspase-9, but not caspase-8, abolished PSAP-induced apoptosis.
Lanes 5 and 6 of top panels in a and b show complete knockdown of caspase-9 and
caspase-8, respectively. Lanes 2, 4, and 6 of the second panels in A and B show the in-
duced expression of PSAP. The third panels in A and B were probed for PARP cleavage.
The fourth, ﬁfth, and sixth panels in A were probed for caspase-8, -3, and -7, respective-
ly. The fourth, ﬁfth, and sixth panels in B were probed for caspase-9, -3, and -7, respec-
tively. The membrane of the top panels in a and b were reprobed with anti-actin
468 T. Li et al. / Biochimica et Biophysica Acta 1832 (2013) 453–474antibody to indicate relative loading of samples (bottom panel).
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470 T. Li et al. / Biochimica et Biophysica Acta 1832 (2013) 453–474Fig. 5. Knockdown of Apaf-1 abolished PSAP-induced apoptosis, caspase activation,
and Bax translocation, but not cytochrome c release. a. Cells stably expressing
Apaf-1-speciﬁc shRNA were transfected with either LacZ-expressing plasmid (lanes 1
and 3) or PSAP-expressing plasmid (lanes 2 and 4). Top panel, complete knockdown
of Apaf-1 (lanes 3 and 4). Second panel, immunoblot probed with anti-PSAP to deter-
mine the transient expression of PSAP (lanes 2 and 4). The bottom panel is the reprobe
of the membrane in the second panel with anti-LacZ antibody to determine the tran-
sient expression of LacZ (lanes 1 and 3). Third panel, immunoblot probed with
anti-PARP antibody to determine the cleavage of PARP upon expression of PSAP.
Fourth, ﬁfth, sixth, and seventh panel, immunoblots probed with speciﬁc antibodies to
determine the activation of caspase-9, -8, -3, and -7, respectively. Eighth and ninth
panels, immunoblots probed for cytochrome c in cytosolic (eighth panel) and mito-
chondrial (ninth panel) fractions, respectively. Tenth and eleventh panels, immunoblots
probed for Bax in cytosolic (tenth panel) and mitochondrial (eleventh panel) fractions,
respectively. Twelfth and thirteenth panels, immunoblots probed for COX-1 in cytosolic
(twelfth panel) and mitochondrial (thirteenth panel) fractions, respectively. The mem-
brane of the second panel was reprobed with anti-actin antibody to indicate relative
loading of samples (fourteenth panel). b. Quantiﬁcation and statistical analysis of the
Western blot results for cytochrome c release and Bax translocation shown in a. Single,
double, and three asterisks indicate signiﬁcant differences between control and treat-
ment at pb0.05 0.01, and 0.001 respectively.
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Fig. 6. Knockdown of Smac abolished PSAP-induced apoptosis, caspase activation, and
Bax translocation, but not cytochrome c release. a. Cells expressing inducible PSAP
were treated with transfection reagent (lanes 1 and 2), control non-silencing siRNA
(lanes 3 and 4), and siRNA-speciﬁc to Smac (lanes 5 and 6). Complete knockdown of
Smac was determined in Smac-siRNA treated cells (top panel, lanes 5 and 6). Second
panel, immunoblot probed with anti-PSAP to determine the inducible expression of
PSAP (lanes 2, 4, and 6). Third panel, immunoblot probed with anti-PARP antibody to
determine the cleavage of PARP upon induction of PSAP expression. Fourth, ﬁfth,
sixth, and seventh panels, immunoblots probed with speciﬁc antibodies to determine
the activation of caspase-9, -8, -3, and -7, respectively. Eighth and ninth panels, immu-
noblots probed for cytochrome c in cytosolic (eighth panel) and mitochondrial (ninth
panel) fractions, respectively. Tenth and eleventh panels, immunoblots probed for Bax in
cytosolic (tenth panel) and mitochondrial (eleventh panel) fractions, respectively.
Twelfth and thirteenth panels, immunoblots probed for COX-1 in cytosolic (twelfth
panel) and mitochondrial (thirteenth panel) fractions, respectively. The membrane of
the second panel was reprobed with anti-actin antibody to indicate relative loading
of samples (fourteenth panel). b. Quantiﬁcation and statistical analysis of the Western
blot results for cytochrome c release and Bax translocation shown in a. Single, double,
and three asterisks indicate signiﬁcant differences between control and treatment at
472 T. Li et al. / Biochimica et Biophysica Acta 1832 (2013) 453–474pb0.05 0.01, and 0.001 respectively.
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Fig. 7. Schematic diagram of death receptor (DR) and mitochondrial pathways for the induction of apoptosis. In the extrinsic DR pathway, ligation of DR (for example, FAS–FASL)
results in the formation of DISC leading to the activation of caspase-8, which might lead directly to the activation of caspase-3 or caspase 7, which in turn cleaves intracellular sub-
strates, resulting in apoptosis. In the traditional intrinsic mitochondrial pathway, intracellular death signals, such as DNA damage and other cellular stress signals, are transmitted to
the mitochondria through pro-apoptotic Bcl-2 family proteins, such as Bid and Bax. Activated Bid (tBid) stimulates Bax to translocate to the outer mitochondrial membrane where it
forms a complex with Bak resulting in the release of cytochrome c (purple), Smac/DIABLO (blue), and other apoptogens (not shown). The anti-apoptotic Bcl-2 family proteins, such
as Bcl-2 and Bcl-xL (not shown), inhibit this process through interacting with the pro-apoptotic proteins. For review, see [13,30]. However, the mitochondrial pro-apoptotic protein
PSAP induces release of cytochrome c and Smac/DIABLO in a Bcl-2 protein-independent manner, suggesting a new mitochondrial apoptotic pathway. XIAP (X-linked IAP) is an IAP,
which binds and inhibits caspase activity. These caspase inhibitors can be antagonized by the pro-apoptotic protein Smac/DIABLO [31]. Inhibitor of caspase-3-activated DNase
(ICAD) and poly (ADP-ribose) polymerase (PARP) are substrates of caspases.
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